SCHEMBL624005

SCHEMBL624005

N#Cc1c(N2CCOCC2)sc(C(=O)O)c1CBr

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 12/20 0.57
GRIA2 P42262 1/20 0.41
GRIA4 P48058 1/20 0.41
PIK3CD O00329 2/20 0.39
PIK3CB P42338 2/20 0.39
PIK3R1 P27986 5/20 0.37
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MTOR P42345 2/20 0.34
PIK3CG P48736 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GSK3B P49841 1/20 0.33
AR P10275 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17244486 0.88 PIK3CA (0.58) PIK3CAGRIA2GRIA4PIK3CDPIK3CB
SCHEMBL623815 0.88 PIK3CA (0.47) PIK3CAGRIA2GRIA4PIK3R1HSD17B10
SCHEMBL627237 0.83 PIK3CA (0.60) PIK3CAGRIA2GRIA4PIK3CDPIK3CB
SCHEMBL10298687 0.82 PIK3CA (0.54) PIK3CAGRIA2GRIA4PIK3CDPIK3CB
SCHEMBL15925947 0.80 PIK3CA (0.55) PIK3CAGRIA2GRIA4PIK3R1ALDH1A1
SCHEMBL623972 0.80 PIK3CA (0.60) PIK3CAGRIA2GRIA4PIK3CDPIK3CB
SCHEMBL10308535 0.79 PIK3CA (0.54) PIK3CAGRIA2GRIA4PIK3CDPIK3CB
SCHEMBL10298704 0.79 PIK3CA (0.69) PIK3CAGRIA2GRIA4KDM4EMTOR
SCHEMBL10308536 0.79 PIK3CA (0.51) PIK3CAGRIA2GRIA4PIK3CDPIK3CB
SCHEMBL10298736 0.79 PIK3CA (0.40) PIK3CAPIK3R1HSD17B10KDM4EMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603214-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-06-19 EP disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed